HSP prevented BON cancer cell proliferation and induced cancer cell death by decreasing achaete-scute complex-like 1(ASCL1), chromogranin A (CgA), and enhanced Notch 1 expression [108]. The gene discussed is NOTCH1; the disease is hereditary spastic paraplegia.